-
-
News
News Highlights
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueIPC APEX EXPO 2025: A Preview
It’s that time again. If you’re going to Anaheim for IPC APEX EXPO 2025, we’ll see you there. In the meantime, consider this issue of SMT007 Magazine to be your golden ticket to planning the show.
Technical Resources
Key industry organizations–all with knowledge sharing as a part of their mission–share their technical repositories in this issue of SMT007 Magazine. Where can you find information critical to your work? Odds are, right here.
The Path Ahead
What are you paying the most attention to as we enter 2025? Find out what we learned when we asked that question. Join us as we explore five main themes in the new year.
- Articles
- Columns
Search Console
- Links
- Media kit
||| MENU - smt007 Magazine
Cicor, Clayens will Collaborate to Offer One-stop Shop Solutions for Smart Drug Delivery Devices
October 12, 2023 | CicorEstimated reading time: 1 minute
The Cicor Group announces that it has signed a Memorandum of Understanding with Clayens Group for a strategic collaboration to create global one-stop CDMO solutions for demanding applications in medical and industrial markets with a focus on smart drug delivery devices.
Cicor is one of Europe's fastest growing manufacturers of high-reliability electronics for medical, industrial and aerospace & defence applications headquartered in Boudry, Switzerland. Clayens is a European leader in the processing of polymers, composites and precision metal parts, headquartered in Genas, France. With complementary global manufacturing capabilities, a shared vision for innovation and excellence, and extensive technology and market expertise in their respective fields, Cicor and Clayens bring together 7,500 employees at 46 production sites in 16 countries across Europe, East Asia and North America, including 20 state-of-the-art cleanrooms.
This strategic partnership enables both companies to offer a one-stop shop for customized, integrated technology solutions that are unmatched in innovation, quality and efficiency, from concept to market, regardless of complexity. Customers, particularly in the medical technology and industrial markets, will benefit from the combination of Cicor's and Clayens' complementary skills and technologies. The joint offering specifically responds to the growing demand for smart drug delivery devices that significantly improve patient care, enable traceability of high value medicine and ultimately reduce healthcare cost. While developing a joint offering entirely focused on new programs, both companies will remain independent of each other and work at arms-length. The collaboration of Cicor and Clayens as independent groups is endorsed by One Equity Partners (OEP), a shareholder in both companies.
Cicor is committed to leveraging this strategic collaboration to drive innovation and create value for all stakeholders, reinforcing its commitment to excellence in the EMS and plastics industries.